Laura Young, MD, PhD

Assistant Professor of Medicine
Director, Endocrinology Fellowship Program

Specialty Areas

Type 1 diabetes; type 2 diabetes; pre-diabetes; patient-centered care; use of technology in diabetes.

Chronology

MD/PhD in Epidemiology: University of Cincinnati, 2006; Internal Medicine Residency: University of North Carolina, 2003-2006; Specialty Fellowship Training in Endocrinology: University of Pennsylvania, 2006-2010; Assistant Professor of Medicine: University of North Carolina, 2010-present.

Dr. Young specializes in the care of patients with diabetes. She enjoys working closely with patients to help them realize and achieve both their short- and long-term health goals. In addition to her clinical work and research, Dr. Young spends a significant amount of her time at UNC working with trainees. She serves as the Dimock College Advisor within the School of Medicine Advising Program. Dr. Young teaches in the Patient Centered Care Course, where she hopes to inspire the next generation of physicians to embrace patient centered care. She also serves as the Endocrinology Fellowship Program Director.

Dr. Young’s research program focuses on a wide breadth of areas in diabetes, but with a special interest in the use of technology in diabetes. A common thread throughout much of Dr. Young’s research is the use of novel behavioral approaches to improve the care of patients with diabetes. The overarching goal of her clinical and research efforts is to help patients with diabetes live happier, healthier lives.

Along with co-PI Katrina Donahue from Family Medicine, she led the MONITOR trial, one of the first PCORI funded trials to be completed. Published in JAMA Internal Medicine, the trial has received wide recognition and acclaim for demonstrating that in patients with type 2 diabetes not treated with insulin, routine glucose monitoring or advanced monitoring linked to tailored messaging did not improve glycemic control versus no monitoring. This study was also one of the first at UNC to demonstrate our health care systems capabilities to conduct large-scale pragmatic trials on time and within budget with high levels of patient retention and little missing data across the region. She provided leadership in the design of a suite of national studies of continuous glucose monitoring (CGM) and now serves as site PI for the WISDM (Wireless Innovation for Seniors With Diabetes Mellitus) study aimed to evaluate the efficacy of CGM particularly to reduce hypoglycemia (time spent with glucose <70 mg/dl) in elderly patients with type 1 diabetes.

In her free time, Dr. Young enjoys taking long walks, cooking, gardening, and spending time with family and friends.

Selected Bibliography

Young LA, Buse JB, Weaver MA, Vu MB, Mitchell CM, Blakeney T, Grimm K, Rees J, Niblock F, Donahue KE; Monitor Trial Group. Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial. JAMA Intern Med. 2017; 177:920-929. PMID: 28600913.

Trief PM, Xing D, Foster NC, Maahs DM, Kittelsrud JM, Olson BA, Young LA, Peters AL, Bergenstal RM, Miller KM, Beck RW, Weinstock RS; T1D Exchange Clinic Network. Depression in adults in the T1D Exchange Clinic Registry. Diabetes Care. 2014 Jun;37(6):1563-72. doi: 10.2337/dc13-1867. PMID:24855157

Faurot KR, Siega-Riz AM, Gardiner P, Rivera JO, Young LA, Poole C, Whitsel EA, González HM, Chirinos-Medina DA, Talavera GA, Castañeda SF, Daviglus ML, Barnhart J, Giacinto RE, Van Horn L. Comparison of a Medication Inventory and a Dietary Supplement Interview in Assessing Dietary Supplement Use in the Hispanic Community Health Study/Study of Latinos.  Integr Med Insights. 2016 Feb 16;11:1-10. doi: 10.4137/IMI.S25587. eCollection 2016.PMID:26917949